Evidence map›Paper›PMID 29743487›Full record

ArticleScientific reports2018

Mitochondrial Complex I activity signals antioxidant response through ERK5.

Abrar Ul Haq Khan, Nerea Allende-Vega, Delphine Gitenay, Johan Garaude, Dang-Nghiem Vo, Sana Belkhala, Sabine Gerbal-Chaloin, Claire Gondeau, Martine Daujat-Chavanieu, Cécile Delettre and 10 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 43 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Evidence for vitellogenin DNA-binding in honey bees.Protein science : a publication of the Protein Society · 2025
    Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 7 institutions in 3 countries.

Abrar Ul Haq KhanIRMB, INSERM, Univ Montpellier, Montpellier, France.
Nerea Allende-VegaIRMB, INSERM, Univ Montpellier, Montpellier, France.
Delphine GitenayIRMB, INSERM, Univ Montpellier, Montpellier, France.
Johan GaraudeIRMB, INSERM, Univ Montpellier, Montpellier, France.
Dang-Nghiem VoIRMB, INSERM, Univ Montpellier, Montpellier, France.
Sana BelkhalaIRMB, INSERM, Univ Montpellier, Montpellier, France.
Sabine Gerbal-ChaloinIRMB, INSERM, Univ Montpellier, Montpellier, France.
Claire GondeauIRMB, INSERM, Univ Montpellier, Montpellier, France.
Martine Daujat-ChavanieuIRMB, INSERM, Univ Montpellier, Montpellier, France.
Cécile DelettreINSERM U1051, Institute of Neurosciences of Montpellier, Montpellier, France.
Stefania OrecchioniLaboratory of Hematology-Oncology, European Institute of Oncology, Milan, Italy.
Giovanna TalaricoLaboratory of Hematology-Oncology, European Institute of Oncology, Milan, Italy.
Francesco BertoliniLaboratory of Hematology-Oncology, European Institute of Oncology, Milan, Italy.
Alberto AnelDepartment of Biochemistry and Molecular and Cellular Biology, Aragón Health Research Institute (IIS Aragón), University of Zaragoza, Zaragoza, Spain.
José M CuezvaDepartamento de Biología Molecular, Centro de Biología Molecular Severo Ochoa, CSIC-UAM, CIBERER, Universidad autónoma de Madrid, 28049, Madrid, Spain.
Jose A EnriquezCentro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC) Melchor Fernandez Almalgo, 3 28209, Madrid, Spain.ORCID 0000-0002-3671-2961
Guillaume CartronDépartement d'Hématologie Clinique, CHU Montpellier, Université Montpellier I, 80 avenue Augustin Fliche, 34295, Montpellier, France.
Charles-Henri LecellierIGMM, CNRS, Univ. Montpellier, Montpellier, France.
Javier HernandezIRMB, INSERM, Univ Montpellier, Montpellier, France.
Martin VillalbaIRMB, INSERM, Univ Montpellier, Montpellier, France. martin.villalba@inserm.fr.ORCID 0000-0002-4385-4888
Inserm · FREuropean Institute of Oncology · ITCentre National de la Recherche Scientifique · FRCentro de Investigación Biomédica en Red · ESSpanish National Centre for Cardiovascular Research · ESUniversidad de Zaragoza · ESUniversité de Montpellier · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Oxidative phosphorylation (OXPHOS) generates ROS as a byproduct of mitochondrial complex I activity. ROS-detoxifying enzymes are made available through the activation of their antioxidant response elements (ARE) in their gene promoters. NRF2 binds to AREs and induces this anti-oxidant response. We show that cells from multiple origins performing OXPHOS induced NRF2 expression and its transcriptional activity. The NRF2 promoter contains MEF2 binding sites and the MAPK ERK5 induced MEF2-dependent NRF2 expression. Blocking OXPHOS in a mouse model decreased Erk5 and Nrf2 expression. Furthermore, fibroblasts derived from patients with mitochondrial disorders also showed low expression of ERK5 and NRF2 mRNAs. Notably, in cells lacking functional mitochondrial complex I activity OXPHOS did not induce ERK5 expression and failed to generate this anti-oxidant response. Complex I activity induces ERK5 expression through fumarate accumulation. Eukaryotic cells have evolved a genetic program to prevent oxidative stress directly linked to OXPHOS and not requiring ROS.

Indexed as

Antioxidant Response ElementsSignal TransductionActive Transport, Cell NucleusAnimalsCell Line, TumorCell NucleusElectron Transport Complex IGene Expression RegulationHumansMaleMiceMitochondriaMitogen-Activated Protein Kinase 7NF-E2-Related Factor 2Oxidative PhosphorylationReactive Oxygen SpeciesElectron Transport Complex IMitogen-Activated Protein Kinase 7NFE2L2 protein, humanNF-E2-Related Factor 2Reactive Oxygen Species

Identifiers

PMID29743487
PMCPMC5943249
OpenAlexW2802074965

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.